Post-marketing Safety Study of GlaxoSmithKline (GSK) Biologicals' Synflorix™ Vaccine, in Healthy Infants and Children in Sri Lanka

Stopped Lack of clarity regarding the PMS study requirement from the RA and Ethics committee hence it was concluded GSK will submit local PSURs.

Conditions

• Immunisation Against Streptococcus Pneumoniae

Interventions

• OTHER: Synflorix™ data collection

Sponsor

GlaxoSmithKline